GSK
859 hedge funds and large institutions have $14.2B invested in GSK in 2025 Q1 according to their latest regulatory filings, with 90 funds opening new positions, 329 increasing their positions, 278 reducing their positions, and 67 closing their positions.
66% more call options, than puts
Call options by funds: $243M | Put options by funds: $146M
34% more first-time investments, than exits
New positions opened: 90 | Existing positions closed: 67
23% more capital invested
Capital invested by funds: $11.6B → $14.2B (+$2.61B)
18% more repeat investments, than reductions
Existing positions increased: 329 | Existing positions reduced: 278
17% more funds holding in top 10
Funds holding in top 10: 12 → 14 (+2)
1.26% more ownership
Funds ownership: 16.75% → 18.02% (+1.3%)
1% more funds holding
Funds holding: 849 → 859 (+10)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fisher Asset Management
Camas,
Washington
|
+$410M |
| 2 |
Dodge & Cox
San Francisco,
California
|
+$374M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$267M |
| 4 |
Holocene Advisors
New York
|
+$175M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$97.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JEST
JTC Employer Solutions Trustee
St Helier,
Jersey
|
-$184M |
| 2 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$91.5M |
| 3 |
Grantham, Mayo, Van Otterloo & Co (GMO)
Boston,
Massachusetts
|
-$73.7M |
| 4 |
Voloridge Investment Management
Jupiter,
Florida
|
-$73.2M |
| 5 |
AC
Armistice Capital
New York
|
-$73.2M |
GSK Hedge Fund Activity: Q1 2025 in Review
859 of the 7,472 institutional investors tracked by Wall St. Rank reported a position in GSK (GSK) for Q1 2025, worth a combined $14.2B — up 23% from $11.6B a quarter earlier.
Buyers outnumbered sellers: 90 funds opened new GSK positions and 67 closed out — a net gain of 23 holders — while 329 added to existing stakes and 278 trimmed.
The largest buyer was Fisher Asset Management, adding an estimated $410M. The largest seller was JTC Employer Solutions Trustee, cutting an estimated $184M.
- 859 institutional investors held GSK (GSK) as of Q1 2025, up from 849 in Q4 2024.
- Funds reported $14.2B of GSK stock for Q1 2025, up 23% quarter-over-quarter.
- 90 funds opened new GSK positions in Q1 2025 and 67 closed out, a net change of +23 holders.
- The largest GSK buyer in Q1 2025 was Fisher Asset Management, an estimated $410M added.
- The largest GSK seller in Q1 2025 was JTC Employer Solutions Trustee, an estimated $184M sold.
Based on aggregated 13F filings for Q1 2025.